Jo Bhakdi is the Founder & CEO of Quantgene, an early-stage medical technology company that deploys machine learning & advanced genetic sequencing technologies to detect cancer at early stages of development. In 2016, they launched one of the largest clinical trials to assess the feasibility of cell-free DNA technology, with the goal of collecting 10,000 patient blood samples. In this episode, we explore the gaps that exist in the cancer diagnostics space and how innovations in sequencing technologies & machine learning aim to fill those gaps. Furthermore, Jo shares the specific approach that Quantgene is taking, the path to adoption in the current healthcare system, and the key considerations in building a multidisciplinary team.
Hosted by Cynthia Steinhardt and Jenna Glatzer.